CIAM
RKDA icon

Caitong International Asset Management’s Arcadia Biosciences RKDA Stock Holding History

Caitong International Asset Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Buy
+1
New +$1 ﹤0.01% 2911

Other funds holding RKDA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BWM
Bullock Wealth Management Bloomington, Indiana $231M AUM

Caitong International Asset Management's RKDA Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2911 among its holdings.

18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • Caitong International Asset Management held 1 share of Arcadia Biosciences worth $1 as of Q2 2026.
  • Arcadia Biosciences was a new Caitong International Asset Management position in Q2 2026.
  • Arcadia Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2911 holding.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.